Screener
Pacira BioSciences, Inc. PCRX Pre-Tax Income
Pre-Tax Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Interest expense | (3,699) | (4,580) |
| Other, net | (135) | 4,401 |
| Total other (expense) income, net | (1,904) | 6,716 |
| Income before income taxes | 4,998 | 8,706 |
| Income tax expense | (2,082) | (3,894) |
| Net income | $2,916 | $4,812 |
| Net income per common share: | ||
| Basic and diluted net income per common share | $0.07 | $0.10 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s pre-tax income?
- Pacira BioSciences, Inc. (PCRX) reported pre-tax income of $5M in Q1 2026.
- How has Pacira BioSciences, Inc.'s pre-tax income changed year-over-year?
- Pacira BioSciences, Inc.'s pre-tax income decreased by 42.6% year-over-year, from $8.71M to $5M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Pacira BioSciences, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude